CareFusion — Q2 2011 Earnings Presentation
20 slides from CareFusion's earnings presentation, Feb 3, 2011
Slide 1: Q2 and 1H Fiscal 2011 Investor/Analyst Call
Exhibit 99.2 Q2 and 1H Fiscal 2011 Investor/Analyst Call February 3, 2011 © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 2: Forward-Looking Statements and GAAP Reconciliation
Forward-Looking Statements and GAAP Reconciliation “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or develo
Slide 3: Today's Speakers
Today’s Speakers • Kieran Gallahue, Chairman and Chief Executive Officer • Dave Schlotterbeck, Outgoing Chairman and Chief Executive Officer • Jim Hinrichs, Chief Financial Officer © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved. 3
Slide 4: Q2 and 1H Fiscal 2011 Results
Q2 and 1H Fiscal 2011 Results © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 5: Q2 Fiscal 2011 Year-Over-Year Quarterly Review
Q2 Fiscal 2011 Year-Over-Year Quarterly Review GAAP Adjusted 1 1 $M %Change $M %Change Revenue $1,002 (2)% $1,002 (2)% 2 Operating Expenses $349 (1)% $320 (3)% 2 Operating Income $126 (1)% $155 4% Income from Continuing 3 $76 4% $98 11% Operations Diluted EPS from Continuing 3 $0.34 3% $0.44 13% Ope
Slide 6: Q2 Fiscal 2011 Year-Over-Year Quarterly Segment Review
Q2 Fiscal 2011 Year-Over-Year Quarterly Segment Review GAAP Adjusted 1 1 Critical Care Technologies (CCT) $M % Change $M % Change Revenues $684 -- $684 -- 2 Segment Profit $110 (1)% $128 2% Medical Technologies and Services 1 1 $M % Change $M % Change (MTS) Revenues $318 (6)% $318 (6)% 2 Segment Pro
Slide 7: 1H Fiscal 2011 Review
1H Fiscal 2011 Review GAAP Adjusted 1 1 $M % Change $M % Change Revenue $1,910 (2)% $1,910 (2)% 2 Operating Expenses $707 3% $638 (1)% 2 Operating Income $208 (15)% $277 (2)% Income from Continuing 3 $114 (11)% $165 (5)% Operations Diluted EPS from Continuing 3 $0.51 (12)% $0.73 (8)% Operations 1 %
Slide 8: 1H Fiscal 2011 Segment Review
1H Fiscal 2011 Segment Review GAAP Adjusted 1 1 Critical Care Technologies (CCT) $M % Change $M % Change Revenues $1,301 -- $1,301 -- 2 Segment Profit $181 (15)% $228 (4)% Medical Technologies and Services 1 1 $M % Change $M % Change (MTS) Revenues $609 (5)% $609 (5)% 2 Segment Profit $27 (16)% $49
Slide 9: Fiscal 2011 Guidance
Fiscal 2011 Guidance © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 10: Fiscal 2011 Financial Guidance
Fiscal 2011 Financial Guidance Feb. 3, 2011 Previous Updated Updated FY11 Outlook, $ in millions 1 FY11 Outlook FY11 Outlook Adjusted for Divestitures² Low single digit growth over Low single digit growth over Mid single digit growth over FY10 reported revenue of FY10 revenue of $3.5B on a Total Rev
Slide 11: Updated Fiscal 2011 Revenue Guidance and Assumptions
Updated Fiscal 2011 Revenue Guidance and Assumptions Guidance • Revenue growth lowered to low single digit growth Assumptions • Infusion revenue lowered as timing of infusion pump conversions shifts a portion of revenue from FY11 to FY12 • Over 50% of revenue expected in 2H FY11 • Hospital capital s
Slide 12: Updated Fiscal 2011 Adjusted EPS Guidance and Assumptions
Updated Fiscal 2011 Adjusted EPS Guidance and Assumptions Guidance • Adjusted diluted EPS expected to be in the range of $1.58 to $1.65 Assumptions • Flexibility on operating expense line partially offsets impact of lower revenue • Lowered FY11 tax rate guidance of 28% to 30% provides ~$0.04 benefit
Slide 13: Updated Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results
Updated Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows on a percentage basis by mid single digits Infusion: Revenues grow on a percentage basis in the low teens due to Medegen acquisition and from incremental market share gains in 2H FY11 following FDA re
Slide 14: Updated Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results
Updated Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows low single digits ChloraPrep ® business grows double digits based on successful execution of growth strategy both domestically and internationally Medical Specialties business continues to grow, drive
Slide 15: Fiscal 2010 Results with ISP as D.O. At a Glance
Fiscal 2010 Results with ISP as D.O. At a Glance FY10 FY10 GAAP FY10 Adjusted $ in millions Difference As Reported As Adjusted with ISP as D.O. 1 Total Revenue $3,929 $3,929 $3,472 $(457) Gross Margin 47.5% 47.5% 49.9% 2.4% 2 Operating Margin 12.0% 13.8% 14.8% 1.0% Diluted EPS 3 $0.87 $1.42 $1.33 $(
Slide 16: Fiscal 2011 Guidance Walk Over
Fiscal 2011 Guidance Walk Over FY11 Updated FY11 Updated FY11 Guidance Guidance with Guidance, Nov. 2, 2010 Updated Adjusted for 1 2 Assumptions Divestitures Revenue grows Revenue grows Revenue grows mid single digits low single digits low single digits over FY10 reported over FY10 revenue over FY10
Slide 17: Fiscal 2011 Growth Expectations
Fiscal 2011 Growth Expectations Compared to Fiscal 2010 with ISP as D.O. FY10 Adjusted $ in millions 1 FY11 Guidance Growth with ISP as D.O. Low single digit Low single digit Total Revenue $3,472 growth growth Gross Margin 49.9% 50 – 51% 0 – 1 ppt Adjusted Operating 14.8% ~17% ~2 ppt Margin 2 Adjust
Slide 18: Q&A
Q&A © 2011 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Slide 19: Q2 Fiscal 2011 Non-GAAP Reconciliations
Q2 Fiscal 2011 Non-GAAP Reconciliations Q2 FY11 Nonrecurring Q2 FY11 $ in millions GAAP Items 1 Adjusted Operating Expenses $349 $(29) $320 Operating Income $126 $29 $155 Income From Continuing Operations $76 $22 $98 Diluted EPS From Continuing 2 $0.34 $0.10 $0.44 Operations Critical Care Technologi
Slide 20: 1H Fiscal 2011 Non-GAAP Reconciliations
1H Fiscal 2011 Non-GAAP Reconciliations 1H FY11 Nonrecurring 1H FY11 $ in millions 1 GAAP Items Adjusted Operating Expenses $707 $(69) $638 Operating Income $208 $69 $277 Income From Continuing Operations $114 $51 $165 Diluted EPS From Continuing 2 $0.51 $0.23 $0.73 Operations Critical Care Technolo